| Announce Date | 10/28/2025 |
| EPS Normalized Actual | $0.67 (Beat by $0.005) |
| EPS GAAP Actual | $0.67 (Beat by $0.005) |
| Revenue Actual | $3.862B |
| Revenue Surprise | Beat by $3862M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $0.59043 |
| EPS GAAP Estimate | $0.59043 |
| Revenue Estimate | $3.829988766B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 2.43 | 35.42 | 2.37241 | 2.49411 | 1 |
| Dec 2026 | 1.99261 | 43.2 | 1.36226 | 2.25303 | 5 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.55 | 0.02571 | 3.862B | 15.82% | 253.05M |
| FQ1 2025 (Mar 2025) | 0.18 | 0.18 | 3.452B | 13.82% | 3452M |
| FQ4 2024 (Dec 2024) | 0.36 | 0.36 | 3.501B | 14.48% | 3501M |
| FQ3 2024 (Sep 2024) | 0.22 | 0.22 | 3.391B | 6.43% | 3391M |
| FQ2 2024 (Jun 2024) | 0.26 | 0.26 | 3.251B | 0.25% | 3251M |
| FQ1 2024 (Mar 2024) | 0.25 | 0.25 | 2.975B | -6.82% | 2975M |
| FQ4 2023 (Dec 2023) | -0.05 | -0.05 | 2.994B | -13.76% | 2994M |
| FQ3 2023 (Sep 2023) | 0.19 | 0.19 | 3.173B | -9.93% | 3173M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.59043
Consensus Revenue Estimates
3.829988766B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.8737 | -- | 0.853 | 0.8913 | 2 |
| FQ3 2027 (Sep 2027) | 0.77058 | -- | 0.76701 | 0.78005 | 3 |
| FQ2 2027 (Jun 2027) | 0.7512 | -- | 0.74772 | 0.76043 | 5 |
| FQ1 2027 (Mar 2027) | 0.64667 | -- | 0.64367 | 0.65462 | 3 |
| FQ4 2026 (Oct 2026) | 0.59598 | -- | 0.58272 | 0.61136 | 3 |
| FQ3 2026 (Jul 2026) | 0.57343 | -- | 0.56067 | 0.58822 | 5 |
| FQ2 2026 (Jun 2026) | 0.5506 | 0.11 | 0.53223 | 0.5657 | 5 |
| FQ1 2026 (Mar 2026) | 0.51239 | 64.87 | 0.49529 | 0.52644 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 5.01B | -- | 4.92B | 5.09B | 2 |
| FQ3 2027 (Sep 2027) | 4.42B | -- | 4.41B | 4.46B | 2 |
| FQ2 2027 (Jun 2027) | 4.32B | -- | 4.3B | 4.36B | 2 |
| FQ1 2027 (Mar 2027) | 3.87B | -- | 3.86B | 3.91B | 2 |
| FQ4 2026 (Oct 2026) | 3.92B | -- | 3.85B | 4B | 4 |
| FQ3 2026 (Jul 2026) | 3.78B | -- | 3.72B | 3.86B | 5 |
| FQ2 2026 (Jun 2026) | 3.71B | -4.22 | 3.61B | 3.78B | 5 |
| FQ1 2026 (Mar 2026) | 3.55B | 2.71 | 3.46B | 3.62B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.52429 | 0.55 | 0.02571 | 4.67% |
| FQ1 2025 (Mar 2025) | 0.18 | 0.18 | 100% | |
| FQ4 2024 (Dec 2024) | 0.36 | 0.36 | 100% | |
| FQ3 2024 (Sep 2024) | 0.22 | 0.22 | 100% | |
| FQ2 2024 (Jun 2024) | 0.26 | 0.26 | 100% | |
| FQ1 2024 (Mar 2024) | 0.25 | 0.25 | 100% | |
| FQ4 2023 (Dec 2023) | -0.05 | -0.05 | 100% | |
| FQ3 2023 (Sep 2023) | 0.19 | 0.19 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $3.61B | $3.86B | $253.05M | 6.55% |
| FQ1 2025 (Mar 2025) | $0B | $3.45B | $3452M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $3.5B | $3501M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $3.39B | $3391M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $3.25B | $3251M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $2.98B | $2975M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $2.99B | $2994M | 100% |
| FQ3 2023 (Sep 2023) | $0B | $3.17B | $3173M | 100% |